Watch Dr. Loren Walensky talk about the collaborative drug discovery taking place at Dana-Farber Cancer Institute

/in

Loren Walensky, MD, PhD, Associate Professor of Pediatrics, Dana-Farber Cancer Institute and Harvard Medical School, and Principal Investigator, Linde Program in Cancer Chemical Biology, speaks about collaborative drug discovery that is taking place at Dana-Farber Cancer Institute’s Longwood Center.

 

Myxopapillary ependymomas in children: imaging, treatment and outcomes

/in ,

In this month’s featured publication, Drs. Ligon, Beroukhim, Kieran and colleagues published a study of the treatment and outcome of children with myxopapillary ependymomas (MPE), a rare spinal tumor.  They examined the diagnosis, imaging, treatment and clinical outcome of eighteen children over a period of 30 years, and found patients with MPE have an excellent overall clinical survival rate, and recommended that treatment strategies to minimize toxicity due to irradiation and chemotherapy approaches.